News

Law

Asset Management

Investment Banking

Wealth

Hedge Funds

People

Newsletters

Events

Lists

Lazard completes hat-trick with Centerpulse deal

Lazard has advised on its third mergers and acquisitions deal in a week with a role on the Sfr3.3bn (€2.2bn) acquisition of Centerpulse, the Swiss medical technology company.

The bank lined up with bidder Smith & Nephew (S&N), the Anglo-American medical devices group, while Lehman and UBS Warburg represented Centerpulse.

WSJ Logo